Alma Health becomes the first health tech company in the UAE to receive funding from leading U-based investment firm

Hambro Perks is a UK-based investment firm that focuses on private technology investing and has played a significant role in helping Alma Health develop its services and continue to offer seamless solutions to people with chronic conditions

  
Khaldoun Bushnaq and Tariq Seksek

Khaldoun Bushnaq and Tariq Seksek

Abu Dhabi: Thriving Abu Dhabi based start-up, Alma Health is pleased to announce that it is has recently acquired a six-figure investment of funding from Hambro Perks to further the company’s expansion across the GCC region. Hambro Perks is a UK-based investment firm that focuses on private technology investing and has played a significant role in helping Alma Health develop its services and continue to offer seamless solutions to people with chronic conditions.

The significant funding will allow Alma Health the chance to secure numerous new healthcare licenses across various locations in the GCC, including Dubai and Saudi Arabia for example. Saudi Arabia is a major market for Alma Health as roughly 12 million people are living with at least one chronic condition and the Abu Dhabi based company believes they can play a big role. Alma Health strives to transform the typical healthcare experience for people with chronic conditions. The digital health company provides them with a fully digital experience, from a virtual doctor consultation at the tap of a button, to prescription delivery and ongoing care.

Since its launch in mid 2020, Alma Health has received funding from other distinguished investors including the Oman Technology Fund – Wadian Omani sovereign wealth fund, ANNEX Investment fund, as well as strategic angel investors from Saudi and the UAE. Alongside its diverse selection of licensed doctors, Alma Health is accredited by a number of reputable insurance providers in the region such as Thiqa, Daman, NAS Neuron and Oman Insurance.

Alma Health is fully licensed by the Emirate’s Department of Health and strives to update its services to ensure a seamless experience for users. The user's healthcare specialists, insurance providers and Alma Health’s physicians and pharmacists are all connected via the Alma Health Operating System, to ensure every user’s experience is as seamless as possible. The team at Alma Health manage all the hard work to fulfil the needs of users, for example billing the insurance provider, preparing the various medications, and delivering them straight to the user's door within 24 hours.

Alma Health continues to revolutionise the healthcare industry in the region and looks forward to introducing its phenomenal services and expertise to Saudi Arabia in the coming months, with the help of its investors.

For more information on Alma Health please visit:
https://almahealth.io/

-Ends- 

About Alma Health:

Alma Health is a digital health company on a mission to transform the lives of people with chronic conditions and those who care for them by harnessing the power of technology. In an increasingly digital world, Alma Health has created the first digitally native healthcare experience from doctor consultation to delivery of medication, to ongoing care.

At Alma Health, we understand that time is your most valuable asset, so we provide you with virtual access to our licensed healthcare professionals who are specialized in chronic care. We then do all the hard work to fulfill your prescription, bill your insurance provider, prepare your various medications, and deliver them straight to your door within 24 hours. We will also remind you when your prescription is due for a renewal. Our goal is to limit the time you spend managing your condition to an absolute minimum.

Alma Health is currently available in Abu Dhabi and is fully licensed by the Abu Dhabi Department of Health. It is part of the Thiqa, Oman Insurance, Daman, and NAS Neuron insurance networks. Our platform will expand to service the Kingdom of Saudi Arabia in the near future.

Send us your press releases to pressrelease.zawya@refinitiv.com


© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.


More From Press Releases